Article
A mouse B16 melanoma mutant deficient in glycolipids.
Proceedings of the National Academy of Sciences of the United States of America - 29 Mar 1994
Ichikawa S, Nakajo N, Sakiyama H, Hirabayashi Y
Abstract excerpt
Mouse B16 melanoma cell line, GM-95 (formerly designated as MEC-4), deficient in sialyllactosylceramide was examined for its primary defect. Glycolipids from the mutant cells were analyzed by high-performance TLC. No glycolipid was detected in GM-95 cells, even when total lipid from 10(7) cells was analyzed. In contrast, the content of ceramide, a precursor lipid molecule of glycolipids, was normal. Thus, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
